Twelve innovators selected to scale across England’s NHS with support from the NHS Innovation Accelerator

These innovations offer solutions to some of the NHS’ most pressing needs and will be supported over the next three years to scale across England for the benefit of NHS patients and staff.

This year, the NIA sought evidence-based innovations that address key NHS priorities: supporting the workforce, mental health and COVID-19 response. From remote patient monitoring and diagnostics to virtual clinical training for staff, the 2021 cohort represents a range of solutions that are set to transform the health and social care system in England.

Each innovation – and its representative Fellow – were selected through a robust, multi-stage assessment process involving expert clinicians, patients and commercial leads drawn from a range of organisations including NHS England and NHS Improvement, NHSX, the Academic Health Science Networks (AHSNs) and NICE.

Since it launched in 2015, the NIA has supported the uptake and spread of 74 evidence-based innovations across more than 2,475 NHS sites.

In recognition of the new cohort, Professor Stephen Powis, Chair of the NIA and National Medical Director for NHS England and NHS Improvement, said: “From the way we deliver services to how we support the health and social care workforce, innovation has proven critical to ensuring we remain able to care for NHS patients and staff effectively and efficiently.

The 12 innovations joining the NHS Innovation Accelerator in 2021 meet the needs of the NHS at this critical time and will be supported to scale across England for even greater patient benefit.”

UCLPartners has already been supporting two of the successful 12 innovations to be adopted by healthcare providers in our partnership:

• Feebris: a mobile-based software platform powered by AI that helps users (clinical or non-clinical) to detect and triage respiratory deterioration remotely.
• Oxehealth: a contact-free vision-based patient monitoring platform for use in hospitals (mental health) and nursed facilities.

Other innovations announced as part of this year’s NIA cohort are:

• AcuPebble SA100: a wearable CE-marked medical device able to accurately and non-invasively diagnose sleep apnoea from the patient’s home.
• Brain in Hand: a digital innovation using coaching principles and practical support to help people living with anxiety and other neurodevelopmental conditions.
• Cyted: a digital diagnostic infrastructure to provide services for the earlier detection of disease through proprietary machine learning.
• Definition Health: a digital pre- and post-op communications tool between hospital and patient, providing the first end to end journey for surgical patients in the UK.
• Infinity Health: a digital platform on which health and care staff log, share and coordinate their daily tasks in real-time, replacing paper-based manual methods.
• KiActiv: a mentor-guided digital service that empowers people to make sustainable behaviour change in the context of their health, capacity and environment, without the need to visit gyms or clinics.
• Little Journey: a smartphone-based health behaviour modification tool that provides end-to-end support for families to reduce children’s anxiety before a healthcare procedure.
• MUTU System: an at-home online programme of exercises to help women heal and strengthen from pelvic symptoms and associated mental health concerns post-baby.
• Oxford Medical Simulation: providing clinical experiences on demand through the use of virtual reality so doctors and nurses can practice caring for virtual patients whenever they need to.
• Vinehealth: a digital platform that uses behavioural science and AI to improve the quality of life and survival of cancer patients through highly personalised patient support.

The NIA is an NHS England and NHS Improvement initiative delivered in partnership with England’s 15 AHSNs that supports delivery of the NHS Long Term Plan priorities by accelerating uptake of high impact innovations for patient, population and NHS staff benefit, and providing practical insights on spread to inform national strategy.